Dietary Supplement and Prescription Omega-3 Fatty Acid Products Use among Iraqi Consumers in Kirkuk City
| Autor: | Jwan Mohammed |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2024 |
| Předmět: |
omega-3 fatty acids
dietary supplements over the counter History of medicine. Medical expeditions R131-687 General works R5-130.5 Medical philosophy. Medical ethics R723-726 Infectious and parasitic diseases RC109-216 Neoplasms. Tumors. Oncology. Including cancer and carcinogens RC254-282 Medical emergencies. Critical care. Intensive care. First aid RC86-88.9 Dermatology RL1-803 Nursing RT1-120 Computer applications to medicine. Medical informatics R858-859.7 |
| Zdroj: | Kirkuk Journal of Medical Sciences, Vol 12, Iss 2, Pp 36-41 (2024) |
| Druh dokumentu: | article |
| ISSN: | 2790-0207 2790-0215 |
| DOI: | 10.32894/kjms.2024.146994.1094 |
| Popis: | Background: Omega-3 fatty acid products are available as dietary supplements (fish oils) and prescription formulations(omega-3 ethyl ester, icosapent ethyl, omega-3 ethyl ester A, omega-3 carboxylic acids). The study aimed to learn moreabout the prevalence of dietary supplement and prescription omega-3 products use by Iraqi consumers in Kirkuk City, torecord the types of products used and to examine the role of physicians and pharmacists in guiding choices about theseproducts.Methods: A cross-sectional questionnaire-based study was conducted among pharmacists concerning dispensing theprescription only medicine (POM) and over the counter (OTC) omega-3 products. Ninety-three filled questionnaireswere received from pharmacies in Kirkuk city.Results: Over 6 months, 43 patients from 93 (46.2%) were dispensed fish oil supplementations by prescription, and50 patients from 93 (53.7%) were dispensed fish oil preparation without prescription. The nonprescription users wereyounger (32.92 vs. 44.41 years old) and more often female (63% vs. 58%) compared to prescription users. 44% of theOTC group purchased omega-3 as a dietary supplement, 20% used it for hair loss, 14% for treating hypertriglyceridemia,0.08% for improving memory function, and 0.02% for pregnancy care. All the products supplied to customers for variousindications either by prescription or as an OTC were dietary supplements.Conclusion: Healthcare providers and consumers need to distinguish the differences between prescription omega-3products and nonprescription omega-3 dietary supplements to ensure the appropriate use of each product. |
| Databáze: | Directory of Open Access Journals |
| Externí odkaz: |
|